Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.84 |
| ▸ | THRB | P10828 | 9/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.84 |
| ▸ | RECQL | P46063 | 8/20 | 0.84 |
| ▸ | BLM | P54132 | 8/20 | 0.84 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.84 |
| ▸ | BRCA1 | P38398 | 7/20 | 0.84 |
| ▸ | MAPT | P10636 | 7/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.84 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.84 |
| ▸ | TOP2A | P11388 | 5/20 | 0.84 |
| ▸ | STAT6 | P42226 | 5/20 | 0.84 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.84 |
| ▸ | HTT | P42858 | 4/20 | 0.84 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.84 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.84 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13742595 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| SCHEMBL20801118 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| SCHEMBL17899465 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| SCHEMBL14867492 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| SCHEMBL17899481 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| SCHEMBL22513656 | 0.93 | MEN1 (0.88) | MEN1THRBKMT2ARECQLBLM | |
| Detorubicin SCHEMBL29771309 | 0.92 | MEN1 (0.81) | MEN1THRBKMT2ARECQLBLM | |
| Detorubicin SCHEMBL27821471 | 0.92 | MEN1 (0.81) | MEN1THRBKMT2ARECQLBLM | |
| Detorubicin SCHEMBL8642 | 0.92 | MEN1 (0.81) | MEN1THRBKMT2ARECQLBLM | |
| Epirubicin SCHEMBL24421866 | 0.91 | MEN1 (1.00) | MEN1THRBKMT2ARECQLBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8709998-B2 | Peptide vectors | IPSEN PHARMA S.A.S. (FR) | 2014-04-29 | — | — | US | disclosed |
| US-8709998-B2 | Peptide vectors | IPSEN PHARMA S.A.S. (FR) | 2014-04-29 | — | — | US | disclosed |
| US-20070093645-A1 | Peptide vectors | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION (FR) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093645-A1 | Peptide vectors | TP53, VIP, XIAP | MEN1 404/4885THRB 2283/4885KMT2A 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.